[Event Information]The 3rd GSDM International Symposium
“Global Governance and Innovation in the Fields of Medicine and Health” 23rd Feb, 2016 13:30~17:30 (Ito Hall, Ito International Research Center, Hongo Campus of the University of Tokyo)
Implementation Report is here.
Today, the movement of people and goods has increased dramatically. As was highlighted by a number of cases such as the rapid spread of the Ebola outbreak in West Africa or the emergence of new influenza viruses, there exists a wide gap between research and on-site applications in the medical field. Furthermore, such cases also showed the necessity of building an effective and strong risk management system including research and development within global health governance. In addition, societal change including demographic decline and aging population increases the need for new medical technologies and systems based on new values, such as regenerative medicine and personalized medicine.
In the symposium, keeping such issues in mind, we would like to provide a platform for discussing three dimensions of medical health innovation from a global perspective: an overview of the latest issues of research and development, the process of on-site application of research results, and the role of each actor including research institutions, private companies, governments and international organizations. The symposium aims at searching for ways to fill the above-mentioned gap between research and on-site application, as well as the cooperation among the public sector, private sector, and universities for the improvement of global governance.
In addition, we would like to consider the education of future distinguished young researchers and practitioners in this field. What kinds of elements are necessary to train someone capable of developing research but at the same time of applying the research results to the various healthcare settings, responding to on-site demands, and cooperating with a variety of actors? We would like to discuss such topics with panelists from various sectors including GSDM students.
|Date||:||Tuesday, February 23, 2016, 13:30-17:30|
|Venue||:||Ito Hall, Ito International Research Center, Hongo Campus of the University of Tokyo|
|Language||:||English/Japanese simultaneous translation|
|Sponsored by||:||Global Leader Program for Social Design and Management (GSDM), the University of Tokyo|
|Supported by||:||GHIT Fund|
|Admission||:||Free of charge
Pre-registration is required. Please register from here
– Professor Hiroyuki Yamato
GSDM Program Director, Executive Vice President of the University of Tokyo
|13:40-14:10||Crosscutting speeches: Global public health and medical innovation
– Professor Hideaki Shiroyama, GSDM Program Coordinator, Dean of the Graduate School of Public Policy, the University of Tokyo
– Professor Kenji Shibuya, Graduate School of Medicine, the University of Tokyo
– Professor Vish Krishnan, Rady School of Management, University of California, San Diego
|14:10-15:30||Session 1 “Global Health Governance”|
In order to set in place a robust risk management system in the medical and health field, there are three main issues that require consideration: (1) the promotion of investment into research institutions and pharmaceutical companies, (2) the realistic funding and risk management including the improvement of insurance, and (3) the issue of global governance by international organizations, private entities and governments. In this session, experts from international organizations, the Government of Japan, and private sector are invited to discuss how global health governance and risk management frameworks, including research and development mechanisms, should be developed with the cooperation of various actors.
– Professor Hideaki Shiroyama
– Dr. Shams Syed, Coordinator (ad interim), Universal Health Coverage & Quality Unit (QHC) Department of Service Delivery & Safety (SDS) I Health Systems & Innovations Cluster (HIS), World Health Organization
– Mr. Atsuyuki Oike, Ambassador, Assistant Vice-Minister / Director-General for Global Issues, Ministry of Foreign Affairs
– Dr. Tadataka Yamada, Venture Partner, Frazier Healthcare Partners
– Dr. BT Slingsby, CEO and Executive Director, Global Health Innovative Technology (GHIT) Fund
– Mr. Tetsuo Yoshioka, Councillor of the Cabinet Secretariat, Director General of Office for Pandemic Influenza and New Infectious Diseases Preparedness and Response, Office for Ebola Virus Disease Preparedness and Response, and Coordination Office of Measures on Emerging Infectious Diseases
– Naoko Adachi (Graduate School of Medicine, Department of Social Medicine, the University of Tokyo)
– Saki Narita (Graduate School of Medicine, Department of International Health, the University of Tokyo)
– Sho Maekawa (Graduate School of Frontier Sciences, Department of Computational Biology and Medical Sciences, the University of Tokyo)
– Ayako Matsuura (Graduate Schools for Law and Politics, School of Legal and Political Studies, the University of Tokyo)
– Seina Ohe (Graduate School of Frontier Sciences, Department of Computational Biology and Medical Sciences, the University of Tokyo)
|15:55-17:15||Session 2 “Biomedical Innovation”
To fill the gap existing between research and on-site applications, the presence of a “mediator” is necessary – who can engage in research from a global perspective, responding to demands from clinical on-site practice, and applying research results in various clinical fields. In this session, medical researchers and practitioners will discuss possible ways to apply research results to innovation responding to immediate demand.
– Professor Hiroshi Suzuki, Graduate School of Public Policy, the University of Tokyo
– Professor Vish Krishnan
– Professor Mamoru Mitsuishi, GSDM Deputy Program Coordinator, Dean of the School of Engineering, the University of Tokyo
– Mr. Keita Mori, Co-CEO, Chairman, Co-Founder, SanBio, Inc.
– Mr. Masahiko Saito, General Manager, Commercial Risk Solutions Department of Sompo Japan Nipponkoa Insurance Inc.,
– Ms. Hiroko Otsubo, Counsellor, Cabinet Secretariat, office of healthcare policy
– Yuki Usui (Graduate School of Frontier Sciences, Department of Computational Biology and Medical Sciences, the University of Tokyo)
– Toru Takenaga (Graduate School of Frontier Sciences, Department of Computational Biology and Medical Sciences, the University of Tokyo)
– CHANG, Ching-Wen (Graduate School of Frontier Sciences, Department of Computational Biology and Medical Sciences, the University of Tokyo)
– Teemu Mehtonen (Graduate School of Engineering, Department of Mechanical Engineering, the University of Tokyo)
– Noriko Morioka (Graduate School of Medicine, Department of Social Medicine, the University of Tokyo)
– Professor Mamoru Mitsuishi